tradingkey.logo

Precision BioSciences Inc <DTIL.OQ> expected to post a loss of $1.72 a share - Earnings Preview

ReutersMay 9, 2025 4:05 PM
  • Precision BioSciences Inc DTIL.OQ DTIL.O is expected to show a fall in quarterly revenue when it reports results on May 15 for the period ending March 31 2025

  • The Durham North Carolina-based company is expected to report a 71.6% decrease in revenue to $5 million from $17.58 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Precision BioSciences Inc is for a loss of $1.72 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Precision BioSciences Inc is $21.50​, above​ its last closing price of $5.15. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-1.96

-2.22

Missed

-13.1

Sep. 30 2024

-2.23

-1.92

-2.25

Missed

-17

Jun. 30 2024

-1.68

-1.50

4.67

Beat

410.3​

Mar. 31 2024

-2.01

-1.91

-0.35

Beat

81.7

​​Dec. 31 2023

-3.99

-2.05

-4.06

Missed

-98.3

Sep. 30 2023

-5.03

-4.87

-2.10

Beat

56.9​

Jun. 30 2023

-7.52

-7.32

-3.00

Beat

59

Mar. 31 2023

-6.80

-6.78

-6.90

Missed

-1.8

This summary was machine generated May 9 at 16:05 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI